Renewable Energy

Walmart, Merck in blockchain collaboration with FDA

Credit: REUTERS/Brendan McDermid

IBM Corp, Merck & Co, KPMG and Walmart Inc said on Thursday they will be a part of U.S. Food and Drug Administration's pilot program that will explore using blockchain to identify, track and trace prescription drugs.

June 13 (Reuters) - IBM Corp IBM.N, Merck & Co MRK.N, KPMG and Walmart Inc EMT.N said on Thursday they will be a part of U.S. Food and Drug Administration's pilot program that will explore using blockchain to identify, track and trace prescription drugs.

The companies said they would create a shared blockchain network to allow real-time monitoring of products in the pharmaceutical supply chain.

(Reporting by Tamara Mathias in Bengaluru; Editing by Shinjini Ganguli)

((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 806749 1208; Reuters Messaging: tamara.mathias.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Renewable Energy Videos

    #TradeTalks: Financing the transition to renewable energy with green bonds #2021Outlook

    GreenBond Advisors Co-Founders Bill Dale and Jonas Englund join Jill Malandrino on Nasdaq #TradeTalks to discuss financing the transition to renewable energy with green bonds. #2021Outlook

    Nov 24, 2020

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More